| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | SVP, COO &CFO | Director +2 more
3 companies
Labrucherie Gil M is a SVP, COO &CFO at NKTR, with reported holdings spanning 3 companies. Recent filings cover 6 purchases and 55 sales. Those positions are worth an estimated $1.5M at current prices.
Our model assigns Labrucherie Gil M a strong insider score of 84/100, based on 13 past trades. Over a 12-month horizon, 92.3% of those trades were profitable, with an average 12-month return of +74.2%.
Labrucherie Gil M's largest disclosed position is in NKTR as SVP, COO &CFO, worth about $1.2M. The recent filings there lean toward selling, a net 1,139,659 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 27, 2025 | SEPN Septerna, Inc. | Chief Financial Officer | Buy | 10,000 | $5.69 | $56,866.68 | +33.3% | +67.6% | +401.2% | |
| Feb 21, 2025 | SEPN Septerna, Inc. | Chief Financial Officer | Buy | 30,000 | $5.74 | $172,296.90 | New | +63.4% | +370.3% | |
| May 16, 2022 | NKTR Nektar Therapeutics | SVP, COO &CFO | Sell | 17,448 | $3.95 | $68,919.60 | -5.3% | +26.5% | -81.6% | |
| May 4, 2022 | RZLT Rezolute, Inc. | Director | Buy | 52,631 | $3.80 | $199,997.80 | New | -16.4% | -43.5% | |
| Feb 16, 2022 | NKTR Nektar Therapeutics | SVP, COO &CFO | Sell | 7,579 | $10.95 | $82,990.05 | -2.5% | -64.8% | -73.4% | |
| Nov 18, 2021 | NKTR Nektar Therapeutics | SVP, COO &CFO | Sell | 24,149 | $13.10 | $316,390.84 | -8.6% | -4.8% | -70.3% | |
| Aug 17, 2021 | NKTR Nektar Therapeutics | SVP, COO &CFO | Sell | 10,867 | $13.76 | $149,480.61 | -4.3% | -2.4% | -65.5% | |
| May 17, 2021 | NKTR Nektar Therapeutics | SVP, COO &CFO | Sell | 7,898 | $18.30 | $144,533.40 | -3.0% | -24.3% | -78.3% | |
| Feb 16, 2021 | NKTR Nektar Therapeutics | SVP, COO &CFO | Sell | 7,977 | $22.37 | $178,445.49 | -3.0% | - | - | |
| Feb 4, 2021 | NKTR Nektar Therapeutics | SVP, COO &CFO | Sale+OE | 150,000 | $19.86 | $2,979,629.45 | -36.0% | - | - |